Professional Seasonal Analysis for Trading

Rocket Pharmaceuticals, Inc. - Common Stock (RCKT)

Seasonality Analysis

Stocks 12 Years Analyzed

Rocket Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

27.70%
Avg Annual Return
50.3%
Avg Monthly Win Rate
7/12
Positive Months
12
Years Analyzed

Rocket Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -2.85%
27%
Very Weak
February 1.53%
50%
Weak
March WORST -7.95%
33%
Very Weak
April 2.96%
83%
Strong
May -4.34%
36%
Very Weak
June -0.13%
36%
Very Weak
July BEST 13.93%
64%
Strong
August 0.13%
55%
Moderate
September 8.73%
73%
Very Strong
October 5.38%
55%
Moderate
November -0.62%
36%
Very Weak
December 10.94%
55%
Moderate

Rocket Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
27.83
Historical Avg Position
41.35
Deviation
-13.53
Performance
Significantly Below Average

Rocket Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for RCKT with overlay patterns, custom date ranges, and more.

Create Free Account

Rocket Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Rocket Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for RCKT across multiple timeframes.

Create Free Account

About Rocket Pharmaceuticals, Inc. - Common Stock (RCKT) Seasonality

Rocket Pharmaceuticals, Inc. - Common Stock (RCKT) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Rocket Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Rocket Pharmaceuticals, Inc. - Common Stock is historically July, with an average return of 13.93% and a win rate of 64%. Conversely, March tends to be the weakest month, averaging -7.95% return.

Looking at the full calendar year, Rocket Pharmaceuticals, Inc. - Common Stock has an average annual return of 27.70% with an overall monthly win rate of 50.3%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Rocket Pharmaceuticals, Inc. - Common Stock has a consistency score of 44.4 (Poor), based on 12 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Rocket Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Rocket Pharmaceuticals, Inc. - Common Stock (RCKT)?

Historically, July has been the best month for Rocket Pharmaceuticals, Inc. - Common Stock, with an average return of 13.93% and a win rate of 64%. However, past performance does not guarantee future results.

What is the worst month for Rocket Pharmaceuticals, Inc. - Common Stock (RCKT)?

Based on historical data, March has been the weakest month for Rocket Pharmaceuticals, Inc. - Common Stock, with an average return of -7.95%. This is a historical observation and does not guarantee future results.

How reliable is RCKT seasonality data?

The seasonality analysis for Rocket Pharmaceuticals, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Rocket Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Rocket Pharmaceuticals, Inc. - Common Stock (RCKT) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.